ATE445011T1 - Hemopoietin-rezeptor und dafür kodierende genetische sequenzen - Google Patents

Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Info

Publication number
ATE445011T1
ATE445011T1 AT96934193T AT96934193T ATE445011T1 AT E445011 T1 ATE445011 T1 AT E445011T1 AT 96934193 T AT96934193 T AT 96934193T AT 96934193 T AT96934193 T AT 96934193T AT E445011 T1 ATE445011 T1 AT E445011T1
Authority
AT
Austria
Prior art keywords
genetic sequences
receptor
sequences coding
hemopoietin receptor
components
Prior art date
Application number
AT96934193T
Other languages
English (en)
Inventor
Tracy Willson
Nicos Nicola
Douglas Hilton
Donald Metcalf
Jian Zhang
Original Assignee
Zenyth Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27157889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE445011(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AUPN6135A external-priority patent/AUPN613595A0/en
Priority claimed from AUPN7276A external-priority patent/AUPN727695A0/en
Priority claimed from AUPO2208A external-priority patent/AUPO220896A0/en
Application filed by Zenyth Operations Pty Ltd filed Critical Zenyth Operations Pty Ltd
Application granted granted Critical
Publication of ATE445011T1 publication Critical patent/ATE445011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compression, Expansion, Code Conversion, And Decoders (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT96934193T 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen ATE445011T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN6135A AUPN613595A0 (en) 1995-10-23 1995-10-23 A novel haemopoietin receptor and genetic sequences encoding same
AUPN7276A AUPN727695A0 (en) 1995-12-22 1995-12-22 A novel haempoietin receptor and genetic sequences encoding same - II
AUPO2208A AUPO220896A0 (en) 1996-09-09 1996-09-09 A novel haemopoietin receptor and genetic sequences encoding same - III
PCT/AU1996/000668 WO1997015663A1 (en) 1995-10-23 1996-10-23 A novel haemopoietin receptor and genetic sequences encoding same

Publications (1)

Publication Number Publication Date
ATE445011T1 true ATE445011T1 (de) 2009-10-15

Family

ID=27157889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934193T ATE445011T1 (de) 1995-10-23 1996-10-23 Hemopoietin-rezeptor und dafür kodierende genetische sequenzen

Country Status (8)

Country Link
EP (1) EP0907730B1 (de)
JP (2) JP4224135B2 (de)
AT (1) ATE445011T1 (de)
AU (1) AU718899C (de)
CA (1) CA2238080C (de)
DE (1) DE69638050D1 (de)
ES (1) ES2334408T3 (de)
WO (1) WO1997015663A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078494B1 (en) 1996-03-01 2006-07-18 Genetics Institute, Llc Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
US5710023A (en) 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
GB9721961D0 (en) * 1997-10-16 1997-12-17 Glaxo Group Ltd Novel molecules
US6703488B1 (en) * 1998-01-15 2004-03-09 Center For Molecular Medicine And Immunology Antibody/receptor targeting moiety for enhanced delivery of armed ligand
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US7507706B1 (en) * 1998-12-14 2009-03-24 Genetics Institute, Llc Cytokine receptor chain
DK1188830T3 (da) 1999-06-02 2010-04-26 Chugai Pharmaceutical Co Ltd Nyt hæmopoietinreceptorprotein NR10
EP1221482B1 (de) 1999-09-27 2005-12-28 Chugai Seiyaku Kabushiki Kaisha HäMOPOIETINREZEPTOR-PROTEIN, NR12
CA2480059C (en) * 2002-03-22 2015-11-24 Amrad Operations Pty. Ltd. Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
AU2003212102B2 (en) * 2002-03-22 2010-01-14 Zenyth Operations Pty Ltd Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1)
MX361174B (es) 2003-12-23 2018-11-29 Genentech Inc Anticuerpos anti-il13 novedosos y sus usos.
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
WO2006055638A2 (en) 2004-11-17 2006-05-26 Abgenix, Inc. Fully human monoclonal antibodies to il-13
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
ES2544888T3 (es) 2006-06-08 2015-09-04 Chugai Seiyaku Kabushiki Kaisha Prevención o remedio para enfermedades inflamatorias
ES2501947T3 (es) 2006-10-19 2014-10-02 Csl Limited Antagonistas de anticuerpos de alta afinidad del receptor alfa 1 de interleucina
EP2076285A4 (de) 2006-10-19 2010-06-30 Merck Sharp & Dohme Antikörper-antagonisten des interleukin-13-rezeptor 1
PL2068922T3 (pl) 2006-10-19 2012-11-30 Csl Ltd Przeciwciała anty-IL-13R alfa1 i ich zastosowania
CA2708065C (en) 2007-12-05 2015-02-24 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for pruritus
AU2008337904B2 (en) 2007-12-15 2014-02-13 F. Hoffmann-La Roche Ag Distinguishing assay
JP6563910B2 (ja) 2013-07-04 2019-08-21 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血清サンプル中の抗薬物抗体を検出するための干渉抑制イムノアッセイ
SG11201601823TA (en) 2013-09-13 2016-04-28 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
PL3044323T3 (pl) 2013-09-13 2022-06-27 F.Hoffmann-La Roche Ag Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
CA3045944A1 (en) 2016-12-07 2018-06-14 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
WO2018183932A1 (en) 2017-03-30 2018-10-04 Progenity Inc. Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor
CN113348011B (zh) 2018-11-19 2023-04-18 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
WO2020197502A1 (en) 2019-03-26 2020-10-01 Aslan Pharmaceuticals Pte Ltd Treatment employing anti-il-13r antibody or binding fragment thereof
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
WO2022186773A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
WO2022186772A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2023048650A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
JP2024534717A (ja) 2021-09-27 2024-09-24 アスラン ファーマシューティカルズ ピーティーイー リミテッド 中等症から重症のアトピー性皮膚炎の処置のための方法
WO2023075702A1 (en) 2021-10-29 2023-05-04 Aslan Pharmaceuticals Pte Ltd Anti-il-13r antibody formulation
KR20250075749A (ko) 2022-08-26 2025-05-28 아슬란 파마슈티컬스 피티이 엘티디 항-il13r 항체의 고농도 제형
CN120077070A (zh) 2022-09-06 2025-05-30 亚狮康私人有限公司 皮炎患者的睡眠缺失或睡眠障碍的治疗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US6274708B1 (en) * 1994-09-05 2001-08-14 Amrad Operations Pty Ltd. Mouse interleukin-11 receptor
WO1996011213A1 (en) * 1994-10-07 1996-04-18 Amgen Boulder Inc. Dimeric il-4 inhibitors
FR2742156A1 (fr) * 1995-12-06 1997-06-13 Sanofi Sa Polypeptide recepteur de l'il-13

Also Published As

Publication number Publication date
DE69638050D1 (de) 2009-11-19
CA2238080A1 (en) 1997-05-01
AU718899C (en) 2004-01-29
JP4224135B2 (ja) 2009-02-12
EP0907730A4 (de) 2001-11-07
WO1997015663A1 (en) 1997-05-01
JP2008029340A (ja) 2008-02-14
AU718899B2 (en) 2000-04-20
JPH11514873A (ja) 1999-12-21
ES2334408T3 (es) 2010-03-09
AU7266896A (en) 1997-05-15
EP0907730B1 (de) 2009-10-07
EP0907730A1 (de) 1999-04-14
CA2238080C (en) 2012-03-13

Similar Documents

Publication Publication Date Title
DE69638050D1 (de) Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
NO995182D0 (no) Pattedyrcytokinlignende faktor 7
DE69918946D1 (de) Rezeptoren für il-18
DE69131249D1 (de) Durch menschliche lymphozyten produzierte proteine, die für diese proteine kodierende dns und pharmazeutische und biologische verwendungen
HUP0101022A1 (hu) Kinolinszármazékok gyógyászati alkalmazása
ATE309375T1 (de) Onkostatin- m rezeptor
PT915974E (pt) Ligandos de receptores de tie-2 modificados
SE9301755D0 (sv) A method of determining affinity and kinetic properties
DE69428689D1 (de) Hefe zellen so konstruiert, dass sie proteinsurrogate des pheromensystems produzieren und anwendungen dafuer
ID1044B (id) Antibodi terubah dan pembuatannya
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
GR3019849T3 (en) Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis
BR0207933A (pt) Mutantes de interleucina-18, sua produção e uso
DE69535831D1 (de) Hemopoietin-rezeptor
DE69725611D1 (de) Nicht-Nukleotid verknüpfende Reagentien
WO1998011225A3 (en) A novel haemopoietin receptor and genetic sequences encoding same
DE60031576D1 (en) Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
DE69935782D1 (de) Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
TR199701469T1 (xx) �i�man (OB) proteinin etkilerini de�i�tiren bile�imlerin meydana ��kar�lmas� i�in y�ntem.
MX9702863A (es) Proteinas asociadas con el hipocampo, secuencias de adn que codifican para las mismas y usos de las mismas.
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
DE69505191D1 (de) Mikrogel enthaltende anionische wasserdispergierbare Harzzusammensetzung und Zusammensetzung für Elektrotauchlackierung, welche diese enthält
ATE332974T1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
DE59611293D1 (de) Protein mit dnase-aktivität
ATE308564T1 (de) Zusammensetzungen und verfahren des synaptischen aktivierungsproteins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties